BrightSpring Q2 revenue $3.15B (+29% YoY); Adj. EBITDA $143M (+29%); raises FY2025 guidance

BrightSpring Health Services, Inc.

2025-Q2 EPS reported $0.27 revenue$6,025,827,000

Net revenue $3,148M (+29.1% YoY); net income from cont. ops $8.5M (flat YoY).
Adjusted EBITDA $143M (+28.8%); Pharmacy Solutions segment EBITDA $125M (+32%).
Full-year 2025 guidance raised: revenue $12.2-12.6B, Adj. EBITDA $590-605M.
Divestiture of Community Living to Sevita on track for Q4 2025.
CEO cites strong performance across Pharmacy and Provider segments.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.